Literature DB >> 18591345

Cardiovascular adverse effects during itraconazole therapy.

S-L Fung, C-H Chau, W-W Yew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18591345     DOI： 10.1183/09031936.00021208

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

Review 1.  Treatment principles for the management of mold infections.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

Review 2.  Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?

Authors:  Daniela Baracaldo-Santamaría; Juan David Cala-Garcia; Germán José Medina-Rincón; Luis Carlos Rojas-Rodriguez; Carlos-Alberto Calderon-Ospina
Journal:  Antibiotics (Basel)       Date:  2022-05-12

3.  Cardiac arrest provoked by itraconazole and amiodarone interaction: a case report.

Authors:  Angeliki M Tsimogianni; Ilias Andrianakis; Alex Betrosian; Emmanouil Douzinas
Journal:  J Med Case Rep       Date:  2011-07-29

4.  The Many Faces of Itraconazole Cardiac Toxicity.

Authors:  Hilary R Teaford; Omar M Abu Saleh; Hector R Villarraga; Mark J Enzler; Christina G Rivera
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-08-15

Review 5.  Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Authors:  Vinayak Palve; Yi Liao; Lily L Remsing Rix; Uwe Rix
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

Review 6.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.